CHTH · As filed with the SEC
CNL Healthcare Properties cash flow statement, by quarter
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) · USD thousands
| USD thousands | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating activities: | ||||||||
| Net cash flows provided by operating activities | 13,427† | 16,165† | 14,300 | 9,325† | 10,312† | 13,505† | 7,148 | 7,338† |
| Investing activities: | ||||||||
| Acquisition of joint venture interest, net of cash acquired | — | — | — | — | — | — | — | 0† |
| Capital expenditures | (4,407)† | (4,508)† | (2,259) | (6,977)† | (3,519)† | (2,994)† | (2,652) | (5,405)† |
| Purchase of held-to-maturity securities | — | — | — | 0† | 0† | — | — | 0† |
| Proceeds from maturity of short-term securities | — | — | — | 0† | 0† | 0† | 0 | 15,000† |
| Other investing activities | — | — | — | — | — | — | — | 0† |
| Net cash flows used in investing activities | (4,407)† | (4,508)† | (2,259) | (6,977)† | (3,519)† | (2,994)† | (2,652) | 9,595† |
| Financing activities: | ||||||||
| Distributions to stockholders | (4,453)† | (4,453)† | (4,453) | (4,453)† | (4,453)† | (4,453)† | (4,453) | (4,453)† |
| Repayments on credit facilities | 0† | (5,000)† | 0 | 0† | 0† | 0† | (10,000) | (190,770)† |
| Draws under credit facilities | 0† | 0† | 16,000 | 16,000† | 0† | 0† | — | 190,770† |
| Purchase of interest rate cap | — | — | — | 0† | (100)† | 0† | 0 | (74)† |
| Distributions to noncontrolling interests | — | — | — | — | — | — | 0 | (29)† |
| Principal payments on mortgages and other notes payable | 0† | 0† | (15,850) | (20,314)† | (218)† | (218)† | (218) | (217)† |
| Other financing activities | 0† | 0† | (36) | 14† | (7)† | 0† | (7) | 551† |
| Net cash flows used in financing activities | (4,453)† | (9,453)† | (4,339) | (10,296)† | (4,778)† | (4,671)† | (14,678) | (16,742)† |
| Net increase (decrease) in cash and restricted cash | 4,567† | 2,204† | 7,702 | (7,948)† | 2,015† | 5,840† | (10,182) | 191† |
| Cash and restricted cash at beginning of period | 55,519 | 53,315 | 45,613 | 53,561 | 51,546 | 45,706 | 55,888 | 55,697 |
| Cash and restricted cash at end of period | 60,086 | 55,519 | 53,315 | 45,613 | 53,561 | 51,546 | 45,706 | 55,888 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.
